Table 2.

Anticancer agents associated with an increased risk of venous thromboembolism.

  • L-Asparaginase

  • Bevacizumab

  • Bleomycin

  • Carmustine

  • Cisplatin

  • 5-Fluorouracil

  • Mitomycin C

  • Tamoxifen

  • Thalidomide and derivatives in association with chemotherapy or high dose dexamethasone

  • Vinca alkaloids

 

  • L-Asparaginase

  • Bevacizumab

  • Bleomycin

  • Carmustine

  • Cisplatin

  • 5-Fluorouracil

  • Mitomycin C

  • Tamoxifen

  • Thalidomide and derivatives in association with chemotherapy or high dose dexamethasone

  • Vinca alkaloids

 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal